Further, we evaluated serum metabolites in patients with CMT1A, CMTX1, CMT2A, HINT1, other genetic subtypes, unknown genetic type and mild, medium, severe degree of CMT. This evidence concerns the gene PMP22 and Charcot-Marie-Tooth disease.